Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Roskilde Fødeklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   5.4% 11.5% 5.3% 2.9% 2.4% 4.3% 17.4% 17.4%   Credit score (0-100)   43 22 42 56 64 47 9 9   Credit rating   BBB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   38.5 1,365 2,551 2,656 2,509 2,701 0.0 0.0   EBITDA   38.5 -330 501 718 565 11.0 0.0 0.0   EBIT   24.3 -383 455 689 544 -9.5 0.0 0.0   Pre-tax profit (PTP)   10.3 -411.5 436.0 678.3 539.2 -10.9 0.0 0.0   Net earnings   7.9 -321.4 338.8 528.2 424.0 -7.9 0.0 0.0   Pre-tax profit without non-rec. items   10.3 -411 436 678 539 -10.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   213 160 115 86.0 64.5 61.4 0.0 0.0   Shareholders equity total   57.9 -264 75.3 603 799 556 262 262   Interest-bearing liabilities   511 465 139 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   424 814 848 1,230 1,094 819 262 262   Net Debt   511 331 -334 -626 -508 -345 -262 -262     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   38.5 1,365 2,551 2,656 2,509 2,701 0.0 0.0   Gross profit growth   0.0% 3,443.0% 86.9% 4.1% -5.5% 7.7% -100.0% 0.0%   Employees   4 4 4 4 4 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   424 814 848 1,230 1,094 819 262 262   Balance sheet change%   0.0% 91.9% 4.3% 45.1% -11.1% -25.1% -68.1% 0.0%   Added value   38.5 -329.7 500.7 717.7 572.4 11.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   199 -107 -90 -57 -43 -24 -61 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   63.1% -28.1% 17.9% 25.9% 21.7% -0.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.7% -51.0% 47.3% 66.3% 46.8% -1.0% 0.0% 0.0%   ROI %   4.3% -74.0% 134.0% 167.3% 77.1% -1.4% 0.0% 0.0%   ROE %   13.6% -73.8% 76.2% 155.6% 60.5% -1.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   13.7% -24.5% 8.9% 49.0% 73.0% 67.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,325.6% -100.4% -66.6% -87.2% -89.8% -3,141.3% 0.0% 0.0%   Gearing %   882.1% -176.3% 184.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 5.8% 6.4% 15.4% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.6 0.9 1.8 3.4 2.7 0.0 0.0   Current Ratio   0.5 0.6 0.9 1.8 3.4 2.7 0.0 0.0   Cash and cash equivalent   0.0 133.6 472.9 625.8 507.6 344.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -190.5 -461.0 -76.1 484.5 700.0 442.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   10 -82 125 179 143 2 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   10 -82 125 179 141 2 0 0   EBIT / employee   6 -96 114 172 136 -2 0 0   Net earnings / employee   2 -80 85 132 106 -2 0 0